Marksans Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
576.54
590.93
550.23
510.13
496.99
Other Income Qtr Cr16.534.8019.0010.1011.01
Operating Revenues Qtr560.01586.13531.24500.03485.98

*All values are in Cr.

Operating Expenses Qtr
450.37
453.11
417.29
398.07
376.43
Operating Profit Qtr
109.64
133.02
113.95
101.97
109.55
EBIDT Qtr Cr
126.17
137.82
132.95
112.06
120.56
Depreciation Qtr
21.06
22.00
17.55
13.66
13.94
Net Profit Qtr
78.29
83.24
83.52
68.66
81.93
Basic EPS Qtr
1.73
1.84
1.84
1.52
1.97
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -